Delivery Order SPE2DR25D9367-SPE2DR26FKKC7
- Not listed
- The Defense Logistics Agency awarded a $5,539.20 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries no set-aside designation. The contract represents a tactical procurement action supporting the Department of Defense's medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,431.36 to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA. The product will be delivered to Park Ridge, Illinois, where the vendor is headquartered. No...
- The U.S. government agency Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,080.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a completion date of February 13, 2024, is for the delivery of VARIVAX vaccine with diluents to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. also holds a larger Indefinite Delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $23,706.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Varivax vaccine with diluents. The contract, issued on August 5, 2025, with an ultimate completion date of August 8, 2025, operates under a firm fixed-price delivery order structure with no set-aside designation. This delivery order falls under DMS...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order to DMS Pharmaceutical Group Inc. for $5,926.60 to supply Varivax vaccine with diluents. The order, issued on September 10, 2025, with an ultimate completion date of September 15, 2025, utilizes a firm fixed-price contract type with no set-aside designation. Performance will occur at DMS Pharmaceutical Group's facility in Park Ridge, Illinois. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a $4,520 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Varivax vaccine with diluents. The award, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency valued at $1,130.00 for the supply of Varivax vaccine with diluents. The award, made on June 26, 2025, with an ultimate completion date of June 27, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,323.97 to DMS Pharmaceutical Group Inc. for the supply of Varivax vaccine with diluents. The award, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. This delivery order carries no set-aside designation and will be performed at the contractor's facility in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,431.36 by the Defense Logistics Agency for the supply of Varivax vaccine with diluents. The contract, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a standard procurement action with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,080.74 contract is for the delivery of VARIVAX vaccine with diluents by February 2, 2024. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the DLA, valued at up to $4,999,999 through 2025, which enables the agency to order a...
- SPE2DR25D9367Indefinite Delivery Contract
- SPE2DR25D9367-SPE2DR26FKKC7Delivery Order
The Defense Logistics Agency (DLA) issued a delivery order valued at $2,216.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Varivax vaccine with diluents. The award was made on November 18, 2025, with an ultimate completion date of November 19, 2025, under a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group will perform this work at its location in Park Ridge, Illinois, leveraging its established capabilities as a critical supplier within the federal pharmaceutical supply chain. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA designated as the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), awarded on November 13, 2025, with a ceiling value of $499.999 billion and completion extending through December 31, 2036. The PPV-G GEN V represents a 30-month base period with three 30-month option periods and positions the contractor as one of multiple regional prime vendor suppliers supporting the Department of Defense's comprehensive pharmaceutical and medical consumables requirements across military healthcare facilities worldwide. The broader PPV-G GEN V acquisition strategy carries a total value of $30.3 billion and authorizes DLA to issue delivery orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables to support recurring military medical supply needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/18/25 |